117 related articles for article (PubMed ID: 3193830)
1. Butyric acid: inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth.
Januszewicz E; Rabizadah E; Novogrodsky A; Shaklai M
Med Oncol Tumor Pharmacother; 1988; 5(4):259-63. PubMed ID: 3193830
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
Cashman JD; Eaves AC; Eaves CJ
Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
[TBL] [Abstract][Full Text] [Related]
4. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
Sagayadan GE; Wiernik PH; Sun N; Ahearn G; Thompson D; Hallam SJ; Hu XP; Dutcher JP; Gallagher RE
Leuk Res; 1994 Oct; 18(10):741-8. PubMed ID: 7934131
[TBL] [Abstract][Full Text] [Related]
5. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
Skórski T; Szczylik C; Malaguarnera L; Calabretta B
Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
[TBL] [Abstract][Full Text] [Related]
6. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
8. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
Rosti V; Bergamaschi G; Ponchio L; Cazzola M
Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
[TBL] [Abstract][Full Text] [Related]
9. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
[TBL] [Abstract][Full Text] [Related]
10. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
11. Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors.
Delforge A; Vandenplas B; Lagneaux L; Loos M; Bron D; Debusscher L; Stryckmans P
Eur J Haematol; 1990 May; 44(5):307-11. PubMed ID: 2115009
[TBL] [Abstract][Full Text] [Related]
12. In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside.
Stagno F; Guglielmo P; Consoli U; Inghilterra G; Giustolisi GM; Palumbo GA; Giustolisi R
Acta Haematol; 2000; 104(2-3):57-64. PubMed ID: 11154976
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C
Cancer Res; 1999 Oct; 59(19):5047-53. PubMed ID: 10519422
[TBL] [Abstract][Full Text] [Related]
15. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
16. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
Robak T; Korycka A
Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
[TBL] [Abstract][Full Text] [Related]
17. The biology of normal and neoplastic stem cells in CML.
Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
[TBL] [Abstract][Full Text] [Related]
19. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
[TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemic granulocytes exhibit reduced and altered binding to P-selectin: modification in the CD15 antigens and sialylation.
Vijayan KV; Advani SH; Zingde SM
Leuk Res; 1997 Jan; 21(1):59-65. PubMed ID: 9029187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]